文献速递胃肠外科围术期管理与 ERAS

腹腔镜袖状胃切除术对重度肥胖2型糖尿病患者的5年长期缓解效果

Laparoscopic sleeve gastrectomy: Effect on long-term remission for morbidly obese patients with type 2 diabetes at 5-year follow up.
PubMed 文献 · Surgery · 2017-07-22

法国单中心回顾性分析52例重度肥胖合并2型糖尿病接受腹腔镜袖状胃切除术的患者,5年随访率89%。术后1年2型糖尿病完全缓解并在5年时仍维持缓解者占17%,改善率1年为58%、5年为52%;术前糖化血红蛋白显著升高、年龄较大及术前需胰岛素治疗可能是完全缓解失败的因素。

要点

  • 腹腔镜袖状胃切除术对重度肥胖合并2型糖尿病的长期完全缓解率有限,5年持续完全缓解为17%。
  • 5年时2型糖尿病改善率为52%,低于1年时的58%。
  • 术前糖化血红蛋白显著升高、年龄较大、术前需胰岛素治疗可能预测完全缓解失败。

核心结论

  • 腹腔镜袖状胃切除术对重度肥胖合并2型糖尿病患者具有中等疗效。
  • 术前糖化血红蛋白显著升高、年龄较大及术前需胰岛素治疗可能是术后2型糖尿病完全缓解失败的因素。

研究设计与样本

  • 单中心回顾性研究,法国大学医院,2006年1月至2010年6月共355例重度肥胖手术患者中52例(15%)术前诊断2型糖尿病。
  • 52例中女性31例(60%)、男性21例(40%),平均年龄51±10岁(范围27-67),平均体质指数48±10 kg/m2(范围35-82)。
  • 2型糖尿病平均病程10.8±10.8年;45例术前糖化血红蛋白平均8±2%(范围5.9-12.8),其中17例(38%)糖化血红蛋白≥9%。
  • 术前3例(6%)仅需胰岛素,4例(8%)口服降糖药联合胰岛素,45例(87%)仅口服降糖药。
  • 5年随访体重数据完整者46例,总随访率89%。

主要发现

  • 术后1年达到2型糖尿病完全缓解并在5年随访时仍维持缓解者9例(17%)。
  • 完全缓解的2型糖尿病患者术前均无需胰岛素治疗。
  • 2型糖尿病改善在1年时为30例(58%),5年随访时维持于27例(52%)。

临床怎么用

  • 对重度肥胖合并2型糖尿病患者,腹腔镜袖状胃切除术可作为改善血糖的治疗选择,但应告知长期完全缓解率有限。
  • 术前糖化血红蛋白显著升高、年龄较大或需胰岛素治疗的患者,术后2型糖尿病完全缓解可能性较低,需加强预期管理。

局限性

  • 单中心回顾性研究,样本量较小(52例2型糖尿病患者)。
  • 5年随访体重数据完整者46例,存在失访。
  • 原文未报告混杂因素校正后的分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the short-term, laparoscopic sleeve gastrectomy has been shown to be effective for the treatment of the type 2 diabetes in patients with severe obesity. There are few data with greater follow-up. Our aim was to evaluate the results of laparoscopic sleeve gastrectomy on the control of type 2 diabetes in patients with severe obesity at 5 years at the University Hospital, France. METHODS: From a total of 355 patients with severe obesity operated between January 2006 and June 2010, 52 (15%) had a diagnosis of type 2 diabetes before undergoing laparoscopic sleeve gastrectomy. RESULTS: There were 31 females (60%) and 21 males (40%), with a mean age of 51 ± 10 years (range 27-67) with a mean body mass index of 48 ± 10 kg/m2 (range 35-82). The mean duration of type 2 diabetes was 10.8 ± 10.8 years before bariatric operation. The preoperative glycated hemoglobin was 8 ± 2% (range 5.9-12.8) in 45 patients; 17 patients (38%) had levels of glycated hemoglobin ≥9%. Three patients (6%) required insulin alone, 4 (8%) were taking oral antidiabetic medicine and insulin, and the remaining 45 patients (87%) were taking only oral antidiabetic medicines. The complete data regarding weight loss at 5-year follow-up were obtained for 46 patients, yielding an overall follow-up rate of 89%. The prolonged remission of type 2 diabetes achieved at 1 year that persisted at 5 years of follow-up was present in 9 patients (17%). No patient with complete remission of their type 2 diabetes required insulin preoperatively. Improvement of type 2 diabetes was observed in 30 patients (58%) at 1 year, which was maintained for 27 patients (52%) at 5-year follow-up. CONCLUSION: Laparoscopic sleeve gastrectomy has demonstrated a moderate efficacy in the treatment morbidly obese patients with type 2 diabetes. Markedly increased preoperative glycated hemoglobin levels, older age, and preoperative need for insulin treatment may be the factors predicting failure of complete remission of type 2 diabetes after laparoscopic sleeve gastrectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Nedelcu M, Loureiro M, Skalli M, et al. Laparoscopic sleeve gastrectomy: Effect on long-term remission for morbidly obese patients with type 2 diabetes at 5-year follow up. Surgery. 2017. PMID: 28739091. doi:10.1016/j.surg.2017.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。